$ICGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Icagen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Icagen, Inc.. Get notifications about new insider transactions in Icagen, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 28 2019 | ICGN | Icagen, Inc. | TAGLICH ROBERT | 10% Owner | Option Exercise | A | 3.50 | 71,428 | 249,998 | 114,285 | |
Aug 28 2019 | ICGN | Icagen, Inc. | TAGLICH ROBERT | 10% Owner | Option Exercise | A | 3.50 | 71,428 | 249,998 | 71,428 | |
Aug 28 2019 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 71,428 | 249,998 | 114,285 | |
Aug 28 2019 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 71,428 | 249,998 | 71,428 | |
May 01 2019 | ICGN | Icagen, Inc. | Cunningham, Richard Anthony | Chief Executive Off ... | Option Exercise | A | 3.50 | 154,616 | 541,156 | 154,616 | |
May 01 2019 | ICGN | Icagen, Inc. | Krafte Douglas | Chief Scientific Of ... | Option Exercise | A | 3.50 | 75,267 | 263,435 | 75,267 | |
Nov 16 2018 | ICGN | Icagen, Inc. | Cunningham, Richard Anthony | Chief Executive Off ... | Option Exercise | A | 3.50 | 535,000 | 1,872,500 | 535,000 | |
Nov 16 2018 | ICGN | Icagen, Inc. | KABATZNIK CLIVE | Director | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 | |
Nov 16 2018 | ICGN | Icagen, Inc. | KORB MARK JOHN | Chief Financial Off ... | Option Exercise | A | 3.50 | 100,000 | 350,000 | 100,000 | |
Nov 16 2018 | ICGN | Icagen, Inc. | Krafte Douglas | Chief Scientific Of ... | Option Exercise | A | 3.50 | 120,000 | 420,000 | 120,000 | |
Nov 16 2018 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 | |
Nov 16 2018 | ICGN | Icagen, Inc. | Roffman Edward | Director | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 | |
Nov 16 2018 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 | |
Nov 16 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 100,000 | 350,000 | 100,000 | |
Nov 16 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 25,000 | 87,500 | 25,000 | |
Aug 29 2018 | ICGN | Icagen, Inc. | TAGLICH ROBERT | 10% Owner | Option Exercise | A | 3.50 | 42,857 | 150,000 | 42,857 | |
Aug 29 2018 | ICGN | Icagen, Inc. | TAGLICH ROBERT | 10% Owner | Option Exercise | A | 3.50 | 42,857 | 150,000 | 42,857 | |
Aug 29 2018 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 42,857 | 150,000 | 42,857 | |
Aug 29 2018 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 42,857 | 150,000 | 42,857 | |
Aug 15 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 45,000 | 157,500 | 45,000 | |
Aug 15 2018 | ICGN | Icagen, Inc. | TAGLICH ROBERT | 10% Owner | Option Exercise | A | 3.50 | 3,750 | 13,125 | 3,750 | |
Aug 15 2018 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 3,750 | 13,125 | 3,750 | |
Aug 15 2018 | ICGN | Icagen, Inc. | KABATZNIK CLIVE | Director | Option Exercise | A | 3.50 | 22,500 | 78,750 | 22,500 | |
Jul 17 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 114,284 | 399,994 | 685,704 | |
Jul 17 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 114,284 | 399,994 | 685,704 | |
Jun 01 2018 | ICGN | Icagen, Inc. | KABATZNIK CLIVE | Director | Option Exercise | A | 3.50 | 28,571 | 99,999 | 28,571 | |
Jun 01 2018 | ICGN | Icagen, Inc. | KABATZNIK CLIVE | Director | Option Exercise | A | 3.50 | 28,571 | 99,999 | 28,571 | |
Apr 06 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 571,428 | 1,999,998 | 571,428 | |
Apr 06 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 571,428 | 1,999,998 | 571,428 | |
Jan 02 2018 | ICGN | Icagen, Inc. | Cunningham, Richard Anthony | Chief Executive Off ... | Option Exercise | A | 3.50 | 5,357 | 18,750 | 5,357 | |
Jan 02 2018 | ICGN | Icagen, Inc. | Cunningham, Richard Anthony | Chief Executive Off ... | Buy | P | 0.37 | 21,428 | 7,928 | 21,428 | 0 to 21.4 K |
Jan 02 2018 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 3.50 | 2,500 | 8,750 | 2,500 | |
Jan 02 2018 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 3.50 | 2,857 | 10,000 | 2,857 | |
Jan 02 2018 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Buy | P | 0.37 | 10,000 | 3,700 | 74,736 | 64.7 K to 74.7 K (+15.45 %) |
Jan 02 2018 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Buy | P | 0.37 | 11,428 | 4,228 | 64,736 | 53.3 K to 64.7 K (+21.44 %) |
Jan 02 2018 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 5,358 | 18,753 | 5,358 | |
Jan 02 2018 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Buy | P | 0.37 | 21,429 | 7,929 | 62,727 | 41.3 K to 62.7 K (+51.89 %) |
Jan 02 2018 | ICGN | Icagen, Inc. | TAGLICH ROBERT | Director | Option Exercise | A | 3.50 | 5,357 | 18,750 | 5,357 | |
Jan 02 2018 | ICGN | Icagen, Inc. | TAGLICH ROBERT | Director | Buy | P | 0.37 | 21,429 | 7,929 | 72,125 | 50.7 K to 72.1 K (+42.27 %) |
Jan 02 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 5,357 | 18,750 | 5,357 | |
Jan 02 2018 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Buy | P | 0.37 | 21,428 | 7,928 | 164,284 | 142.9 K to 164.3 K (+15.00 %) |
Apr 14 2017 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 3.50 | 6,000 | 21,000 | 6,000 | |
Apr 14 2017 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 7,500 | 26,250 | 7,500 | |
Apr 14 2017 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 75,000 | 262,500 | 75,000 | |
Apr 14 2017 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 75,000 | 262,500 | 75,000 | |
Apr 14 2017 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 7,820 | 27,370 | 7,820 | |
Apr 14 2017 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 3.50 | 6,000 | 21,000 | 6,000 | |
Mar 16 2017 | ICGN | Icagen, Inc. | Cunningham, Richard Anthony | Chief Executive Off ... | Option Exercise | A | 3.50 | 20,000 | 70,000 | 20,000 | |
Mar 16 2017 | ICGN | Icagen, Inc. | KABATZNIK CLIVE | Director | Option Exercise | A | 3.50 | 10,000 | 35,000 | 10,000 | |
Mar 16 2017 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 3.50 | 10,000 | 35,000 | 10,000 | |
Mar 16 2017 | ICGN | Icagen, Inc. | Roffman Edward | Director | Option Exercise | A | 3.50 | 10,000 | 35,000 | 10,000 | |
Mar 16 2017 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 10,000 | 35,000 | 10,000 | |
Mar 16 2017 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 10,000 | 35,000 | 10,000 | |
Jul 07 2016 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 15,000 | 52,500 | 15,000 | |
Jul 05 2016 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 3.50 | 37,500 | 131,250 | 37,500 | |
Jul 05 2016 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 3.50 | 37,500 | 131,250 | 0 | |
Jul 05 2016 | ICGN | Icagen, Inc. | KABATZNIK CLIVE | Director | Option Exercise | A | 3.50 | 7,500 | 26,250 | 7,500 | |
Jul 05 2016 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 3.50 | 7,500 | 26,250 | 7,500 | |
Jul 05 2016 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 3.50 | 7,500 | 26,250 | 0 | |
Jul 05 2016 | ICGN | Icagen, Inc. | Roffman Edward | Director | Option Exercise | A | 3.50 | 3,750 | 13,125 | 3,750 | |
Jun 14 2016 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 37,500 | 131,250 | 37,500 | |
Jun 14 2016 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 3.50 | 7,500 | 26,250 | 7,500 | |
May 20 2016 | ICGN | Icagen, Inc. | Krafte Douglas | Chief Scientific Of ... | Option Exercise | A | 3.50 | 100,000 | 350,000 | 100,000 | |
May 20 2016 | ICGN | Icagen, Inc. | Roffman Edward | Director | Option Exercise | A | 3.50 | 12,500 | 43,750 | 12,500 | |
May 20 2016 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 3.50 | 12,500 | 43,750 | 12,500 | |
May 20 2016 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 3.50 | 12,500 | 43,750 | 12,500 | |
May 20 2016 | ICGN | Icagen, Inc. | KABATZNIK CLIVE | Director | Option Exercise | A | 3.50 | 12,500 | 43,750 | 12,500 | |
May 20 2016 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 3.50 | 12,500 | 43,750 | 12,500 | |
Jun 18 2015 | ICGN | Icagen, Inc. | Warner Benjamin | Chief Scientific Of ... | Sell | J | 0.00 | 150,000 | 0 | 1,497,385 | 1.6 M to 1.5 M (-9.11 %) |
Jun 12 2015 | ICGN | Icagen, Inc. | Roffman Edward | Director | Grant | A | 0.00 | 19,000 | 0 | 29,000 | 10 K to 29 K (+190.00 %) |
Mar 06 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | X | 0.01 | 10,000 | 100 | 0 | |
Mar 06 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Buy | J | 0.01 | 10,000 | 100 | 106,615 | 96.6 K to 106.6 K (+10.35 %) |
Mar 06 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | X | 0.01 | 12,500 | 125 | 0 | |
Mar 06 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Buy | J | 0.01 | 12,500 | 125 | 82,595 | 70.1 K to 82.6 K (+17.83 %) |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 1.93 | 67,857 | 130,625 | 67,857 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 2.75 | 67,857 | 186,607 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 1.75 | 60,000 | 105,000 | 60,000 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 2.50 | 60,000 | 150,000 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 1.75 | 20,000 | 35,000 | 20,000 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 2.50 | 20,000 | 50,000 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 1.75 | 41,354 | 72,370 | 41,354 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 2.50 | 41,354 | 103,385 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 2.10 | 60,000 | 126,000 | 60,000 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 3.00 | 60,000 | 180,000 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 1.75 | 60,000 | 105,000 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 1.75 | 20,000 | 35,000 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 1.75 | 41,354 | 72,370 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Buy | J | 0.00 | 101,596 | 0 | 781,173 | 679.6 K to 781.2 K (+14.95 %) |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Buy | J | 0.00 | 33,865 | 0 | 679,577 | 645.7 K to 679.6 K (+5.24 %) |
Feb 03 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Buy | J | 0.00 | 70,095 | 0 | 70,095 | 0 to 70.1 K |
Feb 03 2015 | ICGN | Icagen, Inc. | Warner Benjamin | Chief Scientific Of ... | Option Exercise | J | 1.75 | 63,201 | 110,602 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | Warner Benjamin | Chief Scientific Of ... | Buy | J | 0.00 | 106,824 | 0 | 3,294,769 | 3.2 M to 3.3 M (+3.35 %) |
Feb 03 2015 | ICGN | Icagen, Inc. | KABATZNIK CLIVE | Director | Option Exercise | J | 2.10 | 30,000 | 63,000 | 30,000 | |
Feb 03 2015 | ICGN | Icagen, Inc. | KABATZNIK CLIVE | Director | Option Exercise | J | 3.00 | 30,000 | 90,000 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 1.93 | 63,788 | 122,792 | 63,788 | |
Feb 03 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 2.75 | 63,788 | 175,417 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 1.75 | 30,737 | 53,790 | 30,737 | |
Feb 03 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 2.50 | 30,737 | 76,843 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 2.10 | 15,000 | 31,500 | 15,000 | |
Feb 03 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 2.10 | 30,000 | 63,000 | 30,000 | |
Feb 03 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 3.00 | 45,000 | 135,000 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 1.75 | 30,737 | 53,790 | 0 | |
Feb 03 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Buy | J | 0.00 | 52,099 | 0 | 96,615 | 44.5 K to 96.6 K (+117.03 %) |
Feb 02 2015 | ICGN | Icagen, Inc. | Cunningham, Richard Anthony | President and CEO | Option Exercise | A | 1.75 | 500,000 | 875,000 | 500,000 | |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 1.75 | 168,888 | 295,554 | 168,888 | |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 1.75 | 7,143 | 12,500 | 161,428 | |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 1.75 | 142,857 | 250,000 | 154,285 | |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 1.75 | 2,857 | 5,000 | 11,428 | |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 1.75 | 2,857 | 5,000 | 8,571 | |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 1.75 | 2,857 | 5,000 | 5,714 | |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 1.75 | 2,857 | 5,000 | 2,857 | |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Grant | A | 0.00 | 28,572 | 0 | 645,712 | 617.1 K to 645.7 K (+4.63 %) |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Grant | A | 0.00 | 571,428 | 0 | 617,140 | 45.7 K to 617.1 K (+1,250.06 %) |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Grant | A | 0.00 | 11,428 | 0 | 45,712 | 34.3 K to 45.7 K (+33.33 %) |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Grant | A | 0.00 | 11,428 | 0 | 34,284 | 22.9 K to 34.3 K (+50.00 %) |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Grant | A | 0.00 | 11,428 | 0 | 22,856 | 11.4 K to 22.9 K (+100.00 %) |
Jan 09 2015 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Grant | A | 0.00 | 11,428 | 0 | 11,428 | 0 to 11.4 K |
Jan 09 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 1.75 | 146,810 | 256,918 | 146,810 | |
Jan 09 2015 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Grant | A | 0.00 | 48,800 | 0 | 48,800 | 0 to 48.8 K |
Jan 09 2015 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 1.75 | 71,428 | 124,999 | 71,428 | |
Jan 09 2015 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Grant | A | 0.00 | 285,712 | 0 | 285,712 | 0 to 285.7 K |
Apr 04 2014 | ICGN | Icagen, Inc. | TYSON TIMOTHY | Director | Option Exercise | A | 2.50 | 132,000 | 330,000 | 132,000 | |
Apr 03 2014 | ICGN | Icagen, Inc. | Roffman Edward | Director | Option Exercise | A | 2.50 | 20,000 | 50,000 | 20,000 | |
Apr 03 2014 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | A | 2.50 | 20,000 | 50,000 | 20,000 | |
Apr 03 2014 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 0.01 | 27,500 | 275 | 12,500 | |
Apr 03 2014 | ICGN | Icagen, Inc. | TAGLICH MICHAEL N | Director | Option Exercise | J | 2.75 | 217,534 | 598,219 | 67,857 | |
Apr 03 2014 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | A | 2.50 | 20,000 | 50,000 | 20,000 | |
Apr 03 2014 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 0.01 | 10,000 | 100 | 10,000 | |
Apr 03 2014 | ICGN | Icagen, Inc. | Palmieri Vincent | Director | Option Exercise | J | 2.75 | 63,788 | 175,417 | 63,788 | |
Apr 03 2014 | ICGN | Icagen, Inc. | Warner Benjamin | Director | Option Exercise | J | 0.00 | 63,201 | 0 | 63,201 | |
Apr 03 2014 | ICGN | Icagen, Inc. | Warner Benjamin | Director | Option Exercise | J | 0.00 | 23,035 | 0 | 0 | |
Apr 03 2014 | ICGN | Icagen, Inc. | Warner Benjamin | Director | Option Exercise | A | 1.50 | 185,000 | 277,500 | 185,000 | |
Apr 03 2014 | ICGN | Icagen, Inc. | Warner Benjamin | Director | Gift | G | 0.00 | 900,000 | 0 | 3,187,945 | 4.1 M to 3.2 M (-22.02 %) |
Page: 1